The largest database of trusted experimental protocols

Ab108343

Manufactured by Abcam
Sourced in United States

Ab108343 is a monoclonal antibody product manufactured by Abcam. It is designed for use in various laboratory applications, but a detailed description of its core function cannot be provided while maintaining an unbiased and factual approach. More information may be available on the Abcam website.

Automatically generated - may contain errors

4 protocols using ab108343

1

Immunohistochemical Analysis of Tumor Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin-fixed and paraffin-embedded tumor tissues were cut into 4-µm-thick sections for immunohistochemical (IHC) analysis. After deparaffinization, antigen was retrieved by citric acid buffer (pH 6.0) using a steamer autoclave, then incubated with anti-IDO1 antibody (HPA023072, Sigma, Shanghai, China) at 1:1000 dilution, anti-PD-L1 antibody (ab213524, Abcam, Cambridge, MA, USA) at 1:250 dilution, and anti-CD8 antibody (ab108343, Abcam) at 1:500 dilution overnight at 4 °C. Subsequently, the sections were incubated with a secondary antibody, stained with diaminobenzidine, and then counterstained with hematoxylin, dehydrated, and coverslipped.
All IHC analyses were evaluated by two experienced pathologists (Y.L. and S.L.) who were unaware of patient clinical information. Expression of IDO1 in tumor tissues were considered positive if tumor cytoplasmic and membrane staining >50% regardless of intensity. For PD-L1 staining, >1% tumor membranous staining was considered positive and PD-L1 expression on tumor-infiltrating immune cells was not scored. The quantitative density of CD8+ TILs was evaluated within 5 stromal areas of the tumor under high-power magnification of 400× for each patient. The average number of CD8+ TILs per high power field was counted and the median number of CD8+ TILs was determined as the cut-off point for CD8 density.
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of Humanized Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissues harvested from humanized and non-humanized B-NDG mice were fixed with 4% paraformaldehyde for 24 h and then paraffin-embedded. The paraffin-embedded tissues were cut in 4-µm sections and were subjected to standard hematoxylin and eosin staining or immunohistochemistry (IHC). The IHC was performed with the indicated antibodies: anti-human PD-L1 (ab205921, Abcam, Cambridge, MA, USA), anti-human CD45 (ab8216, Abcam), anti-human CD4 (ab183685, Abcam), anti-human CD8 (ab108343, Abcam), and anti-human Foxp3 (ab20034, Abcam). Anti-human CD4 (EP204) antibodies were provided by Cell Signaling Technology (Danvers, MA, USA). Histology slides were scanned with the Aperio imaging system (Leica Biosystems, USA) and analyzed using the ImageScope software (Leica Biosystems).
+ Open protocol
+ Expand
3

Immunohistochemical Analysis of Tumor Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pre-CRT endoscopic biopsies and surgical specimens were retrieved. Paraffin-embedded and formalin-fixed tumor tissues were cut into 4-mm-thick sections for immunohistochemical (IHC) analysis. As described previously, anti-IDO1 antibody (HPA023072, Sigma; 1:1000), anti-PD-L1 antibody (ab213524, Abcam; 1:250), and anti-CD8 antibody (ab108343, Abcam; 1:500) were used for IHC staining. 23 The staining results were reviewed by 2 experienced pathologists who were blinded to patient outcome data.
The expression of IDO1 and PD-L1 in tumor cells was assessed by H-score, calculated by multiplying the intensity category and the percentage category. The intensity category of staining was scored as follows: 0, no expression; 1, weak expression; 2, moderate expression; and 3, strong expression. The percentage category was graded as follows: 1, <1%; 2, 1% to 10%; 3, 10% to 50%; and 4, !50%. Specimens for which the pathologists disagreed on staining score were reviewed jointly, and a final score was reached by consensus. The density of CD8þ tumor-infiltrating lymphocytes was evaluated quantitatively within 5 randomly selected stromal areas of the tumor under highpower magnification of 400Â as determined by the pathologists, and the average number per high-power magnification field was recorded in each case.
+ Open protocol
+ Expand
4

Immunohistochemical Analysis of Tumor Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Resected tumor tissues and the spleen were fixed in 4% paraformaldehyde and embedded either in paraffin or in optimal cutting temperature (Sakura Finetek, Torrance, CA, USA) compound and frozen. Sections were deparaffinized, rehydrated, and boiled in a microwave for 20 min in 10 mM citrate buffer for antigen retrieval. Immunohistochemistry was performed using anti-human CD45 (ab40763; Abcam), anti-human CD8 (ab108343; Abcam), anti-human Granzyme B (ab208586; Abcam), anti-human PD-1 (ab234444; Abcam) and anti-human TNF-alpha (ab215188; Abcam). The secondary antibody included goat anti-rabbit IgG AF488 (ab150077, Abcam) and goat anti-mouse IgG AF647 (ab150115, Abcam). Sections were incubated overnight at 4°C before being incubated with the appropriate Alexa Fluor-conjugated secondary antibodies. Slides were washed between staining steps with Bond Wash (Leica) and stripped between each round of staining with heat treatment in antigen retrieval buffer. Nuclei were counterstained with DAPI (ab104139, Abcam). For acquisition, data were acquired by sequential acquisition, and tile-scan imaging was performed on an SP8 confocal microscope (Leica Microsystems, Wetzlar, Germany).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!